Leaflet: information for the user
Risperidone Krka 2 mg film-coated tablets
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
-This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.
1.What Risperidone Krka is and what it is used for
2.What you need to know before you start taking Risperidone Krka
3.How to take Risperidone Krka
4.Possible side effects
5.Storage of Risperidone Krka
6.Contents of the pack and additional information
Risperidona belongs to a group of medicines called “antipsychotics”.
Risperidona Krka is used to treat:
Risperidona may help reduce the symptoms of your illness and prevent them from returning.
Do not take Risperidona Krka
If you are unsure whether this applies to you, consult your doctor or pharmacist before using this medicine.
Warnings and precautions
Consult your doctor or pharmacist before starting to take risperidone:
You may need your dose adjusted.
If you are unsure whether any of the above applies to you, consult your doctor or pharmacist before using this medicine.
Because in very rare cases, a dangerously low number of a type of white blood cell necessary to fight infections in the blood has been observed in patients treated with risperidone, your doctor may check your white blood cell count.
Risperidone may cause weight gain. Significant weight gain can negatively affect your health. Your doctor should weigh you regularly.
Diabetes mellitus or worsening of pre-existing diabetes mellitus has been observed in patients taking risperidone, so your doctor should determine if there are signs of sugar in the blood. In patients with pre-existing diabetes mellitus, blood glucose should be controlled regularly.
Risperidone Krka frequently increases the levels of a hormone called prolactin. This can cause adverse effects such as menstrual disorders or fertility problems in women or breast swelling in men (see Possible side effects). If these adverse effects appear, it is recommended that the levels of prolactin in the blood be evaluated.
During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the coloured part of the eye) may become flaccid during surgery and this may cause eye damage. If you are planning to have eye surgery, make sure to inform your ophthalmologist that you are taking this medicine.
Patients with advanced age and dementia
In patients with advanced age and dementia, there is a higher risk of stroke. Do not take risperidone if you have dementia caused by a stroke.
During treatment with risperidone, you should consult your doctor frequently.
Seek medical attention immediately if you or your caregiver notice a sudden change in your mental state, sudden weakness or numbness of the face, arms or legs, especially on one side, or difficulty speaking, even for a short period of time. These may be symptoms of a stroke.
Children and adolescents
Before starting treatment for conduct disorders, other causes of aggressive behaviour should be ruled out.
If during treatment with risperidone fatigue occurs, a change in the administration regimen may improve attention deficits.
Before starting treatment, your weight or that of your child should be measured and monitored regularly during treatment.
A small, inconclusive study has reported an increase in the height of children taking risperidone, but it is unknown whether this is due to the drug or another reason.
Other medicines and Risperidona Krka
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine.
It is especially important to inform your doctor or pharmacist if you are taking:
The following medicines may reduce the effect of risperidone:
If you start or stop taking these medicines, you may need a different dose of risperidone.
The following medicines may increase the effect of risperidone:
If you start or stop taking these medicines, you may need a different dose of risperidone.
If you are unsure whether any of the above applies to you, consult your doctor or pharmacist before using this medicine.
Taking Risperidona Krka with food, drinks and alcohol
You can take this medicine with or without food, but you should avoid drinking alcohol while taking risperidone.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medicine.Your doctor will decide if you can take this medicine.
The following symptoms may appear in newborns of mothers who have taken risperidone in the last trimester (the last three months of pregnancy): tremors, stiffness and/or muscle weakness, drowsiness, agitation, difficulty breathing and difficulty feeding. If your baby shows any of these symptoms, it may be necessary to contact your doctor.
Risperidone may increase the levels of a hormone called“prolactin” which may affect fertility (see Possible side effects).
Driving and operating machinery
During treatment with Risperidona Krka, dizziness, fatigue and vision problems may occur. Do not drive or operate tools or machinery without consulting your doctor first.
Risperidona Krka contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1mmol of sodium (23mg) per tablet; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is as follows:
For the treatment of schizophrenia
Adults
Older adults
For the treatment of mania
Adults
Older adults
For the treatment of prolonged aggression in patients with Alzheimer's disease
Adults (including older adults)
Use in children and adolescents
For the treatment of behavioral disorders
The dose depends on the child's weight:
For children weighing less than 50 kg
For children weighing 50 kg or more
Theduration of treatment in patients with behavioral disorders should not be prolonged for more than 6 weeks.
Children under 5 years old should not be treated with risperidone for behavioral disorders.
Patients with kidney or liver problems
Regardless of the disease being treated, all initial and subsequent doses should be reduced by half. Dose increases should be slower in these patients.Risperidone should be used with caution in this group of patients.
Administration form
For oral use
Swallow the tablet with water.
If you take more Risperidone Krka than you should
If you forget to take Risperidone Krka
If you interrupt treatment with Risperidone Krka
You should not stop taking this medication unless your doctor tells you to. It is possible that symptoms will reappear. If your doctor decides to stop treatment, the dose should be gradually reduced over a few days.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 1,000 people):
Inform your doctor immediately if you experience any of the following rare side effects (may affect up to 1 in 1,000 people):
The following side effects may occur:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Rare (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency unknown: the frequency cannot be estimated from available data
The following side effects have appeared with the use of another medication called paliperidone, which is very similar to risperidone, so it is also expected to appear with Risperidone Krka: Fast heart rate when standing up.
Other side effects in children and adolescents
In general, it is expected that side effects in children will be similar to those that appeared in adults.
The following side effects were reported more frequently in children and adolescents (5 to 17 years) than in adults: Feeling drowsy, or less attentive, fatigue (tiredness), headache, increased appetite, vomiting, common cold symptoms, nasal congestion, abdominal pain, dizziness, cough, fever, tremor (shaking), diarrhea, and urinary incontinence.
Reporting side effects
If you experienceany type of side effect, consult your doctor or pharmacist, even if it is apossibleside effect that does not appear in this leaflet.You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keepthis medicationout of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging after CAD.The expiration date is the last day of the month indicated.
PVC/PE/PVDC-Alu blister:Store below 30°C.
HDPE container: This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE point of your pharmacy.Ask your pharmacist how to dispose of the containers and medications you no longer need. In this way, you will help protect the environment.
Risperidone Krka Composition
The active ingredient is risperidone.
Each film-coated tablet contains2 mg of risperidone.
The other components are:
Core:lactose monohydrate, powdered cellulose, microcrystalline cellulose, sodium croscarmellose, anhydrous colloidal silica, sodium lauryl sulfate, magnesium stearate.
Tablet coating:hypromellose, titanium dioxide(E171), talc, propylene glycol,iron oxide red (E172), iron oxide yellow (E172).
See section 2 “Risperidone Krka contains lactose and sodium”.
Appearance of the product and contents of the pack
Film-coated tabletorange, oval, biconvex, scored on one side.
The tablet can be divided into equal doses.
Pack sizes
Blister packs: 20, 28, 30, 56, 60 or 100 film-coated tablets in a box.
Plastic container: 500 film-coated tablets in a plastic container.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
For further information about this medicinal product, please contact the Marketing Authorization Holder’s Representative in your country:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
DenmarkRisperidon Krka
FinlandRisperidon Krka 0.5 mg/1 mg/2 mg/3 mg/4 mg/6 mg Film-coated Tablets
PortugalRisperidona Krka
SwedenRisperidon Krka 0.5 mg/1 mg/2 mg/3 mg/4 mg/6 mg Film-coated Tablet
SlovakiaTorendo 0.5 mg/1 mg/2 mg/3 mg/4 mg/6 mg
SpainRisperidona Krka 0.5 mg/1 mg/2 mg/3 mg/4 mg/6 mg Film-coated Tablets
Last review date of this leaflet: March 2023
Further information about this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.